The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas

Area of Science:

• Oncology
• Molecular Biology
• Gynecologic Pathology

Background:

• Endometrial cancer is a prevalent gynecologic malignancy.
• E-cadherin, a tumor suppressor, is often downregulated in cancers.
• Snail, a transcription factor, negatively regulates E-cadherin and is linked to estrogen receptor signaling.

Purpose of the Study:

• To investigate the expression patterns of E-cadherin, Snail, and estrogen receptor alpha (ERα) in endometrial carcinomas.
• To determine the correlation between these markers and clinicopathological features, including tumor grade and metastatic potential.

Main Methods:

• Immunohistochemical analysis of E-cadherin, Snail, and ERα in 87 primary endometrial tumors and 26 metastases.
• Correlation analysis with tumor grade and metastatic status.
• In vitro migration assays using endometrial carcinoma cell lines with varying Snail expression levels.

Main Results:

• Reduced E-cadherin was observed in 44.8% of primary tumors and 65.4% of metastases, correlating with higher grade in metastases.
• Snail immunoreactivity was present in 28.7% of primary tumors, associated with reduced ERα expression.
• Snail was found in 53.8% of metastases, correlating with higher grade and abnormal E-cadherin.
• A Snail-expressing cell line exhibited increased migration compared to a low-Snail variant.

Conclusions:

• Snail expression is associated with features of aggressive endometrial cancer, including higher tumor grade and altered E-cadherin levels.
• Snail may play a significant role in endometrial tumor progression and metastasis.
• Targeting Snail could be a potential therapeutic strategy for advanced endometrial carcinomas.